Vitaly Margulis, Christopher G Wood. Show Affiliations »
Abstract
Mesh： See more » Angiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedBevacizumabCarcinoma, Renal Cell/pathologyCarcinoma, Renal Cell/surgeryCarcinoma, Renal Cell/therapyClinical Trials as TopicCombined Modality TherapyHumansIndoles/therapeutic useInterferon-alpha/therapeutic useKidney Neoplasms/pathologyKidney Neoplasms/surgeryKidney Neoplasms/therapyNephrectomy/methodsProtein Kinases/therapeutic usePyrazoles/therapeutic usePyrimidines/therapeutic usePyrroles/therapeutic useSunitinibSurvival AnalysisTOR Serine-Threonine KinasesVascular Endothelial Growth Factor A/antagonists & inhibitors
Substances： See more » 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidineAngiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedIndolesInterferon-alphaPyrazolesPyrimidinesPyrrolesVascular Endothelial Growth Factor ABevacizumabProtein KinasesMTOR protein, humanTOR Serine-Threonine KinasesSunitinib
Year: 2008 PMID： 18206292 DOI： 10.1016/j.eururo.2007.12.041
Source DB: PubMed Journal: Eur Urol ISSN： 0302-2838 Impact factor: 20.096